Pluri PLUR
NASDAQ PLUR
$1.71 -0.05 (-2.84%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pluri (PLUR) Cash & Current Investments (2010 - 2025)

Pluri (PLUR) posted quarterly Cash & Current Investments of $4.9 million for Q4 2025, down 34.39% year-over-year from $7.5 million in Q4 2024, and up 4.84% quarter-over-quarter from $4.7 million in Q3 2025.

Pluri (PLUR) Cash & Current Investments (2010 - 2025) Analysis & Trends

Pluri (PLUR) has reported Cash & Current Investments for 16 consecutive years, with $4.9 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Cash & Current Investments fell 34.39% year-over-year to $4.9 million; the TTM figure through Dec 2025 stood at $4.9 million (down 34.39% YoY), while the FY2025 annual figure was $20.6 million, down 31.26% from the prior year.
  • Cash & Current Investments grew to $4.9 million in Q4 2025 per PLUR's latest filing, from $4.7 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $65.5 million in Q2 2021 and bottomed at $906000.0 in Q1 2023.
  • Historically, Cash & Current Investments has averaged $25.5 million across 5 years, with a median of $20.2 million in 2021.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments plunged 97.06% — and 2024, when it surged 812.14%.
  • Pluri's Cash & Current Investments stood at $19.7 million in 2021, then soared by 139.47% to $47.2 million in 2022, then slumped by 97.06% to $1.4 million in 2023, then surged by 438.46% to $7.5 million in 2024, then sank by 34.39% to $4.9 million in 2025.
  • Business Quant data shows PLUR's Cash & Current Investments at $4.9 million in Q4 2025, $4.7 million in Q3 2025, and $20.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Pluri 16.21 Mn 3.72 Mn 86,000.00 12.48 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 4.91 Mn
Sep 30, 2025 4.69 Mn
Jun 30, 2025 20.61 Mn
Mar 31, 2025 8.91 Mn
Dec 31, 2024 7.49 Mn
Sep 30, 2024 3.56 Mn
Jun 30, 2024 29.99 Mn
Mar 31, 2024 8.26 Mn
Dec 31, 2023 1.39 Mn
Sep 30, 2023 5.55 Mn
Jun 30, 2023 41.07 Mn
Mar 31, 2023 906,000.00
Dec 31, 2022 47.25 Mn
Sep 30, 2022 49.30 Mn
Jun 30, 2022 56.66 Mn
Mar 31, 2022 25.40 Mn
Dec 31, 2021 19.73 Mn
Sep 30, 2021 61.28 Mn
Jun 30, 2021 65.55 Mn
Mar 31, 2021 47.37 Mn